HGBL vs REGN · P/E 19, rev $25.0M vs P/E 14, rev $4.29B
Heritage Global Inc (HGBL) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Heritage Global Inc (HGBL) is a capital markets company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported HGBL revenue for 2026-06-30 was $25.0M. Net income was -$15.2M. Revenue was up 96.4% from 2026-03-31 to 2026-06-30. HGBL currently screens at market cap $81.5M and trailing P/E 19.3.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
HGBL currently screens at market cap $81.5M and trailing P/E 19.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the HGBL and REGN stock pages for the full models.
Not investment advice.